Subacute sclerosing panencephalitis: A preventable terminal neurological illness

References

1. Garg RK. Subacute sclerosing panencephalitis. Postgrad Med J. 2002;78(916):63–70.
2. World Health Organization (WHO). The WHO Weekly Epidemiological Record (WER) [Internet]. Accessed Mar 30, 2022. https://www.who. int/groups/global-advisory-committee-on- vaccine-safety/topics/ measles-vaccines#cms
3. Carter MJ, Willcocks MM, ter Meulen V. Defective translation of measles virus matrix protein in a subacute sclerosing panencephalitis cell line. Nature. 1983;305(5930):153–5.
4. Aysun S, Sanal Ö, Renda Y, Berkel I, Yalaz K, Ersoy F, et al. Cell mediated immunity in patients with subacute sclerosing panencephalitis. Brain Dev. 1984;6(4):391–96.
5. Garg RK, Pandey S. Subacute Sclerosing Panencephalitis: Recent Advances in Pathogenesis, Diagnosis, and Treatment. Ann Indian Acad Neurol. 2025;28(2):159–68.
6. Prashanth LK, Taly AB, Ravi V, Sinha S, Rao S. Long term survival in subacute sclerosing panencephalitis: an enigma. Brain Dev. 2006;28(7):447–52.
7. Samia P, Oyieke K, Tunje D, Udwadia-Hegde A, Feemster K, Oncel I, et al. Options in the treatment of subacute sclerosing panencephalitis: implications for low resource areas. Curr Treat Options Neurol. 2022;24(3):99–110.
8. Garg D, Sharma S. Disease-modifying therapy in subacute sclerosing panencephalitis: An area of darkness. Ann Indian Acad Neurol. 2023;26(1):3–9.
9. Lukban MB, Chua-Macrohon BC, Salonga AM. The Use of Intravenous Immunoglobulin in Subacute Sclerosing Panencephalitis: A Retrospective Cohort Study. Acta Medica Philippina. 2012;46(4):46–50.
10. Garg D, Makharia A, Agarwal A, Garg A, Srivastava AK. Contemporary Treatment Practices for Subacute Sclerosing Panencephalitis: A Nationwide Survey Among Adult and Pediatric Neurologists in India. Ann Indian Acad Neurol. 2024;27(6):684–9.